Literature DB >> 12218887

Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users.

Gwenaëlle M Vidal-Trecan1, Isabelle Varescon-Pousson, Bertrand Gagnière, Stéphanie Tcherny- Lessenot, Eléonore Madariaga, Alain Boissonnas.   

Abstract

HCV infection is rapidly acquired after drug addicts first inject drug intravenously. The risk behaviors accompanying the first intravenous substance injection are not well known. We used in 1997 a structured questionnaire to investigate the relationships between risk behaviors at the first injection and current reported HCV status. We interviewed 151 injecting drug users from four treatment centers and one prison in Paris. Risk markers for reported HCV seroconversion were explored by use of logistic regression models. One hundred and forty-three injecting drug users (95%) agreed to participate in the study. At the first injection, 50% shared preparation equipment; 22% borrowed and 26% lent injecting equipment. At the time of the study, 46% reported that they were HCV-positive. Sharing preparation equipment (odds ratio=3.1; 95% confidence interval: 1.2-7.8) and lending injection equipment (odds ratio=3.0; 95% confidence interval: 1.1-8.5) during the first injection were independently associated with reported HCV seropositivity. The high-risk behaviors accompanying the first intravenous injection of drugs justifies the implementation of specific prevention measures, aimed at young drug users who have not started to inject.

Entities:  

Mesh:

Year:  2002        PMID: 12218887

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  4 in total

Review 1.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

2.  Isolation of hepatitis C virus in norjizac vials.

Authors:  Katayoon Tayeri; Seyed Ramin Radfar; Majid Yaran; Nazila Kassaian; Zary Nokhodian; Behrooz Ataei; Reza Fadaei
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

3.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

4.  Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.

Authors:  Leslie D Williams; Mary Ellen Mackesy-Amiti; Carl Latkin; Basmattee Boodram
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.